Category : Science and TechPublished on: December 13 2024
Share on facebook
Indian scientists have developed for the first time human gene therapy using lentiviral vector for severe hemophilia A, achieving a significant medical milestone.
Indian scientists at the Stem Cell Research Centre (CSCR) of the Christian Medical College (CMC) Vellore developed and conducted successful clinical trials of the country's first human gene therapy for severe hemophilia A, which reduced the bleeding rate to zero and the production of factor VIII continued for a long time.